Search research articles
Contact Us
Filters
Showing results (81-90 of 88) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 88 results.
International Journal of Antimicrobial Agents
|
December 20, 2016
Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study
Philipp Koehler, Axel Hamprecht, Oliver Bader, et al.
Blood
|
April 29, 2015
Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV
Susanne Saussele, Marie-Paloma Krauss, Rüdiger Hehlmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2025
Positron Emission Tomography-Guided Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma: A Prospective, Multicenter, Single-Arm, Phase II Cohort of the German Hodgkin Study Group HD21 Trial
Justin Ferdinandus, Helen Kaul, Alexander Fosså, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 27, 2024
Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia: The Randomized, Placebo-Controlled, Double-Blind, Phase III CLL12 Trial
Petra Langerbeins, Sandra Robrecht, Pascal Nieper, et al.
Cell Reports. Medicine
|
November 20, 2024
Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer
Carsten Denkert, Andreas Schneeweiss, Julia Rey, et al.
Annals of Hematology
|
September 20, 2015
Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML
Alice Fabarius, Lida Kalmanti, Christian T Dietz, et al.
Leukemia
|
October 3, 2018
Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study
Jan Braess, Susanne Amler, Karl-Anton Kreuzer, et al.
Annals of Hematology
|
January 25, 2023
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study
Dietger Niederwieser, Thomas Lang, Rainer Krahl, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 88) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 88 results.
International Journal of Antimicrobial Agents
|
December 20, 2016
Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study
Philipp Koehler, Axel Hamprecht, Oliver Bader, et al.
Blood
|
April 29, 2015
Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV
Susanne Saussele, Marie-Paloma Krauss, Rüdiger Hehlmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2025
Positron Emission Tomography-Guided Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma: A Prospective, Multicenter, Single-Arm, Phase II Cohort of the German Hodgkin Study Group HD21 Trial
Justin Ferdinandus, Helen Kaul, Alexander Fosså, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 27, 2024
Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia: The Randomized, Placebo-Controlled, Double-Blind, Phase III CLL12 Trial
Petra Langerbeins, Sandra Robrecht, Pascal Nieper, et al.
Cell Reports. Medicine
|
November 20, 2024
Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer
Carsten Denkert, Andreas Schneeweiss, Julia Rey, et al.
Annals of Hematology
|
September 20, 2015
Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML
Alice Fabarius, Lida Kalmanti, Christian T Dietz, et al.
Leukemia
|
October 3, 2018
Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study
Jan Braess, Susanne Amler, Karl-Anton Kreuzer, et al.
Annals of Hematology
|
January 25, 2023
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study
Dietger Niederwieser, Thomas Lang, Rainer Krahl, et al.
Page
of 9